Sheng‐Xi Wu
-
- Neuroscience and Neuropharmacology Research 7
- Neuropeptides and Animal Physiology 3
-
- Esophageal Cancer Research and Treatment 8
-
- Pancreatic and Hepatic Oncology Research 4
-
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Diagnosis and Treatment 3
-
- Neonatal and fetal brain pathology 4
-
- Pain Mechanisms and Treatments 4
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Sheng‐Xi Wu
39 papers receiving 608 citations
Peers
Comparison fields: 5 of 89
- Cellular and Molecular Neuroscience 96
- Anesthesiology and Pain Medicine 26
- Biological Psychiatry 11
- Developmental Neuroscience 18
- Sensory Systems 21
Countries citing papers authored by Sheng‐Xi Wu
This map shows the geographic impact of Sheng‐Xi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Xi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Xi Wu more than expected).
Fields of papers citing papers by Sheng‐Xi Wu
This network shows the impact of papers produced by Sheng‐Xi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Xi Wu. The network helps show where Sheng‐Xi Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng‐Xi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2020 | 19 | |
| 5 | 2020 | 24 | |
| 6 | 2020 | 10 | |
| 7 | 2018 | 9 | |
| 8 | 2018 | 18 | |
| 9 | 2018 | 11 | |
| 10 | 2018 | 21 | |
| 11 | 2018 | 19 | |
| 12 | 2015 | 3 | |
| 13 | 2014 | 23 | |
| 14 | 2014 | 18 | |
| 15 | Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma | 2012 | 4 |
| 16 | 2010 | 27 | |
| 17 | 2010 | 5 | |
| 18 | 2009 | 12 | |
| 19 | 2008 | 27 | |
| 20 | Studies on the expression of multiple 5-HT receptor subtype mRNAs in rat retina by RT-PCR | 2005 | 1 |
About Sheng‐Xi Wu
Sheng‐Xi Wu is a scholar working on Developmental Neuroscience, Anesthesiology and Pain Medicine and Cellular and Molecular Neuroscience, having authored 41 papers that have together received 615 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (8 papers), Neuroscience and Neuropharmacology Research (7 papers), Pancreatic and Hepatic Oncology Research (4 papers), Gastric Cancer Management and Outcomes (4 papers), Neonatal and fetal brain pathology (4 papers), Pain Mechanisms and Treatments (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (96 citations), Anesthesiology and Pain Medicine (26 citations) and Biological Psychiatry (11 citations). Sheng‐Xi Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include He-San Luo, He-Cheng Huang, Ze-Sen Du, Howard S. Smith, Wen Wang, Yun-Qing Li, Kaishan Tao, Yongqi Li, Da‐Yong Cao and Ling Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.